Experienced and versatile scientist with a strong background in translational and preclinical research, with focus in cell and gene therapy applications. Over five years of progressive experience at Vor Bio leading cross-functional studies involving patient-derived samples, IND-enabling data generation, and the development of innovative single-cell multi-omics platforms. Proven expertise in CRISPR-Cas9 genome editing, flow cytometry, assay development, and authoring GxP-compliant documentation. Adept at managing collaborations with internal teams and CROs, driving project at the preclinical and early clinical stages.
